创伤靶向递送氨甲环酸在大鼠肝出血模型中改善止血与生存
研究在大鼠肝创伤模型中比较载氨甲环酸的创伤靶向纳米囊泡(T-tNVs)与对照纳米囊泡、游离氨甲环酸及生理盐水,发现T-tNVs在体外可抵抗tPA诱导的溶解,在体内维持全身安全性、显著减少失血并改善生存。
要点
- T-tNVs在体外可抵抗tPA加入的大鼠血液中的溶解。
- 在大鼠肝出血模型中,T-tNVs显著减少失血并改善生存。
- 尸检确认T-tNVs具有全身安全性和创伤靶向活性。
核心结论
- 研究确立靶向递送氨甲环酸可在损伤部位选择性增强和稳定止血 clot,从而改善创伤生存的潜力。
研究设计与样本
- 研究使用脂质体作为模型递送载体,表面修饰纤维蛋白原模拟肽以锚定于创伤相关 clot 内的活化血小板,并包封氨甲环酸,制备载氨甲环酸的创伤靶向纳米囊泡(T-tNVs)。
- T-tNVs 先在大鼠血液中进行体外评价,后在大鼠肝创伤模型中进行体内评价,并与载氨甲环酸的对照(非靶向)纳米囊泡(TNVs)、游离氨甲环酸或生理盐水作为比较组进行研究。
主要发现
- 体外研究表明 T-tNVs 可抵抗加入 tPA 的大鼠血液中的溶解。
- 体内研究表明 T-tNVs 维持全身安全性,在大鼠肝出血模型中显著减少失血并改善生存。
- 对安乐死大鼠切除组织的尸检评估证实 T-tNVs 的全身安全性和创伤靶向活性。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Trauma-associated hemorrhage and coagulopathy remain leading causes of mortality. Such coagulopathy often leads to a hyperfibrinolytic phenotype where hemostatic clots become unstable because of upregulated tissue plasminogen activator (tPA) activity. Tranexamic acid (TXA), a synthetic inhibitor of tPA, has emerged as a promising drug to mitigate fibrinolysis. TXA is US Food and Drug Administration-approved for treating heavy menstrual and postpartum bleeding, and has shown promise in trauma treatment. However, emerging reports also implicate TXA for off-target systemic coagulopathy, thromboembolic complications, and neuropathy. OBJECTIVE: We hypothesized that targeted delivery of TXA to traumatic injury site can enable its clot-stabilizing action site-selectively, to improve hemostasis and survival while avoiding off-target effects. To test this, we used liposomes as a model delivery vehicle, decorated their surface with a fibrinogen-mimetic peptide for anchorage to active platelets within trauma-associated clots, and encapsulated TXA within them. METHODS: The TXA-loaded trauma-targeted nanovesicles (T-tNVs) were evaluated in vitro in rat blood, and then in vivo in a liver trauma model in rats. TXA-loaded control (untargeted) nanovesicles (TNVs), free TXA, or saline were studied as comparison groups. RESULTS: Our studies show that in vitro, the T-tNVs could resist lysis in tPA-spiked rat blood. In vivo, T-tNVs maintained systemic safety, significantly reduced blood loss and improved survival in the rat liver hemorrhage model. Postmortem evaluation of excised tissue from euthanized rats confirmed systemic safety and trauma-targeted activity of the T-tNVs. CONCLUSION: Overall, the studies establish the potential of targeted TXA delivery for safe injury site-selective enhancement and stabilization of hemostatic clots to improve survival in trauma.
引用
- Girish A, Hickman DA, Banerjee A, et al. Trauma-targeted delivery of tranexamic acid improves hemostasis and survival in rat liver hemorrhage model. J Thromb Haemost. 2019. PMID: 31220416. doi:10.1111/jth.14552
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。